Human islet xenotransplantation in rodents: A literature review of experimental model trends

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.72, n.4, p.238-243, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Among the innovations for the treatment of type 1 diabetes, islet transplantation is a less invasive method of treatment, although it is still in development. One of the greatest barriers to this technique is the low number of pancreas donors and the low number of pancreases that are available for transplantation. Rodent models have been chosen in most studies of islet rejection and type 1 diabetes prevention to evaluate the quality and function of isolated human islets and to identify alternative solutions to the problem of islet scarcity. The purpose of this study is to conduct a review of islet xenotransplantation experiments from humans to rodents, to organize and analyze the parameters of these experiments, to describe trends in experimental modeling and to assess the viability of this procedure. In this study, we reviewed recently published research regarding islet xenotransplantation from humans to rodents, and we summarized the findings and organized the relevant data. The included studies were recent reports that involved xenotransplantation using human islets in a rodent model. We excluded the studies that related to isotransplantation, autotransplantation and allotransplantation. A total of 34 studies that related to xenotransplantation were selected for review based on their relevance and current data. Advances in the use of different graft sites may overcome autoimmunity and rejection after transplantation, which may solve the problem of the scarcity of islet donors in patients with type 1 diabetes.
Palavras-chave
Islet Transplantation, Allograft, Transplantation, Heterologous, Islets of Langerhans
Referências
  1. Avgoustiniatos ES, 2012, CELL TRANSPLANT, V21, P2805, DOI 10.3727/096368912X653138
  2. Biancone L, 2007, NMR BIOMED, V20, P40, DOI 10.1002/nbm.1088
  3. Brandhorst D, 2013, APOPTOSIS, V18, P681, DOI 10.1007/s10495-013-0834-6
  4. Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323
  5. Cantaluppi V, 2006, AM J TRANSPLANT, V6, P2601, DOI 10.1111/j.1600-6143.2006.01534.x
  6. de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732
  7. De Sa JR, 2008, ARQ BRAS ENDOCRINOL, V52, P355, DOI 10.1590/S0004-27302008000200024
  8. Eliaschewitz FG, 2009, ARQ BRAS ENDOCRINOL, V53, P15, DOI 10.1590/S0004-27302009000100004
  9. Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4
  10. Fraker C, 2006, CELL TRANSPLANT, V15, P745, DOI 10.3727/000000006783981440
  11. Gao R, 2007, MOL CELL ENDOCRINOL, V264, P28, DOI 10.1016/j.mce.2006.10.007
  12. Gu Z, 2013, ACS NANO, V7, P4194, DOI 10.1021/nn400630x
  13. Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
  14. Hoglund Erika, 2009, JOP, V10, P242
  15. Iuamoto Leandro R., 2014, MedicalExpress (São Paulo, online), V1, P190, DOI 10.5935/MedicalExpress.2014.04.06
  16. Iuamoto LR, 2014, WORLD J GASTROENTERO, V20, P13512, DOI 10.3748/wjg.v20.i37.13512
  17. Jacobs-Tulleneers-Thevissen D, 2010, DIABETOLOGIA, V53, P1690, DOI 10.1007/s00125-010-1721-0
  18. Jacobson S, 2010, SCAND J IMMUNOL, V71, P83, DOI 10.1111/j.1365-3083.2009.02356.x
  19. Lee SH, 2009, TRANSPLANTATION, V87, P983, DOI 10.1097/TP.0b013e31819c86ea
  20. Liu S, 2013, DIABETOLOGIA, V56, P370, DOI 10.1007/s00125-012-2764-1
  21. Lu YX, 2006, MOL THER, V14, P851, DOI 10.1016/j.ymthe.2006.08.007
  22. Luo J, 2013, METABOLISM, V62, P90, DOI 10.1016/j.metabol.2012.07.010
  23. Manikandan R, 2009, MICROSC RES TECHNIQ, V72, P723, DOI 10.1002/jemt.20721
  24. McCall M, 2011, SURGERY, V150, P48, DOI 10.1016/j.surg.2011.02.023
  25. Merani S, 2006, CLIN SCI, V110, P611, DOI 10.1042/CS20050342
  26. Mwangi SM, 2011, TRANSPLANTATION, V92, P745, DOI 10.1097/TP.0b013e31822bc95a
  27. Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P111, DOI 10.3727/000000008783907125
  28. Noguchi H, 2012, CELL TRANSPLANT, V21, P517, DOI 10.3727/096368911X605439
  29. Oh E, 2014, J CLIN ENDOCR METAB, V99, pE866, DOI 10.1210/jc.2013-2221
  30. Path G, 2006, AM J PHYSIOL-ENDOC M, V291, pE1168, DOI 10.1152/ajpendo.00436.2005
  31. Papas KK, 2007, AM J TRANSPLANT, V7, P707, DOI 10.1111/j.1600-6143.2006.01655.x
  32. Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282
  33. Paulsson JF, 2006, DIABETOLOGIA, V49, P1237, DOI 10.1007/s00125-006-0206-7
  34. Pearson T, 2008, DIABETOLOGIA, V51, P1449, DOI 10.1007/s00125-008-1057-1
  35. Perez-Basterrechea M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073526
  36. Pour PM, 2012, PANCREATOLOGY, V12, P57, DOI 10.1016/j.pan.2011.11.002
  37. Qi MRG, 2012, XENOTRANSPLANTATION, V19, P355, DOI 10.1111/xen.12009
  38. Rink JS, 2010, SURGERY, V148, P335, DOI 10.1016/j.surg.2010.05.013
  39. Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
  40. Sabek O, 2010, TRANSPL P, V42, P2112, DOI 10.1016/j.transproceed.2010.05.080
  41. Sabek OM, 2006, TRANSPLANT P, V38, P3678, DOI 10.1016/j.transproceed.2006.10-117
  42. Scharfmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003559
  43. Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
  44. Sklavos MM, 2010, DIABETES, V59, P1731, DOI 10.2337/db09-0588
  45. Toso C, 2010, TRANSPL INT, V23, P259, DOI 10.1111/j.1432-2277.2009.00984.x
  46. van der Laan LJW, 2000, NATURE, V407, P90
  47. Vlad G, 2008, DIABETES, V57, P1878, DOI 10.2337/db08-0054
  48. Wu DC, 2013, TRANSPLANTATION, V96, P707, DOI 10.1097/TP.0b013e31829fa271
  49. Yamamoto T, 2010, TRANSPLANTATION, V89, P1328, DOI 10.1097/TP.0b013e3181d98af1
  50. Zhang JA, 2010, CHINESE MED J-PEKING, V123, P3106, DOI 10.3760/cma.j.issn.0366-6999.2010.21.028